Skip to main content
S 1681 115th Congress Senate Health Drug safety, medical device, and laboratory regulation Health programs administration and funding Health technology, devices, supplies Inflation and prices Intellectual property Medical research Research and development

A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Introduced: July 31, 2017 Introduced by: Sanders, Bernard Independent · Vermont See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 31, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.

What's happening now July 31, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
  • HR 3536 Identical bill To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing ag…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.. 115th Congress. Open America. https://openamerica.io/bill/115-S-1681/
MLA
"S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1681/.
Bluebook (legal)
S. 1681, 115th Cong. (2026), https://openamerica.io/bill/115-S-1681/.
Markdown link
[S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.](https://openamerica.io/bill/115-S-1681/)
Report a problem